198 related articles for article (PubMed ID: 31371263)
1. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings.
Paradela-Dobarro B; Agra RM; Álvarez L; Varela-Román A; García-Acuña JM; González-Juanatey JR; Álvarez E; García-Seara FJ
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1050-1060. PubMed ID: 31371263
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome.
Raposeiras-Roubín S; Rodiño-Janeiro BK; Paradela-Dobarro B; Grigorian-Shamagian L; García-Acuña JM; Aguiar-Souto P; Jacquet-Hervet M; Reino-Maceiras MV; González-Juanatey JR; Álvarez E
PLoS One; 2013; 8(9):e74302. PubMed ID: 24058542
[TBL] [Abstract][Full Text] [Related]
3. Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE.
Moriya S; Yamazaki M; Murakami H; Maruyama K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(10):2540-2546. PubMed ID: 25282185
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of AGEs and soluble RAGE isoforms are associated with all-cause mortality and development of cardiovascular complications in type 2 diabetes: a retrospective cohort study.
Sabbatinelli J; Castiglione S; Macrì F; Giuliani A; Ramini D; Vinci MC; Tortato E; Bonfigli AR; Olivieri F; Raucci A
Cardiovasc Diabetol; 2022 Jun; 21(1):95. PubMed ID: 35668468
[TBL] [Abstract][Full Text] [Related]
5. Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease.
Yang ZK; Shen Y; Shen WF; Pu LJ; Meng H; Zhang RY; Zhang Q; Chen QJ; De Caterina R; Lu L
Int J Cardiol; 2015 Oct; 197():241-7. PubMed ID: 26142969
[TBL] [Abstract][Full Text] [Related]
6. Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study.
Fukushima Y; Daida H; Morimoto T; Kasai T; Miyauchi K; Yamagishi S; Takeuchi M; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M;
Cardiovasc Diabetol; 2013 Jan; 12():5. PubMed ID: 23289728
[TBL] [Abstract][Full Text] [Related]
7. Serum advanced glycation end-products and receptors as prognostic biomarkers in diabetics undergoing coronary artery stent implantation.
Shen Y; Pu LJ; Lu L; Zhang Q; Zhang RY; Shen WF
Can J Cardiol; 2012; 28(6):737-43. PubMed ID: 23073352
[TBL] [Abstract][Full Text] [Related]
8. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Moure-González M; Seoane-Blanco A; Varela-Román A; Almenar-Bonet L; Alvarez E; González-Juanatey JR
Am J Cardiol; 2011 Mar; 107(6):938-44. PubMed ID: 21247530
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.
Raposeiras-Roubín S; Rodiño-Janeiro BK; Paradela-Dobarro B; Grigorian-Shamagian L; García-Acuña JM; Aguiar-Souto P; Jacquet-Hervet M; Reino-Maceiras MV; Alvarez E; González-Juanatey JR
Cardiovasc Diabetol; 2012 Aug; 11():102. PubMed ID: 22909322
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of soluble receptor for advanced glycation end products and coronary atherosclerosis: possible correlation with clinical presentation.
Falcone C; Bozzini S; D'Angelo A; Matrone B; Colonna A; Benzi A; Paganini EM; Falcone R; Pelissero G
Dis Markers; 2013; 35(3):135-40. PubMed ID: 24167358
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in circulating levels of the soluble receptor for advanced glycation endproducts in middle-aged and older adults.
Brinkley TE; Leng X; Nicklas BJ; Kritchevsky SB; Ding J; Kitzman DW; Hundley WG
Metabolism; 2017 May; 70():98-106. PubMed ID: 28403949
[TBL] [Abstract][Full Text] [Related]
13. The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
Willemsen S; Hartog JW; van Veldhuisen DJ; van der Meer P; Roze JF; Jaarsma T; Schalkwijk C; van der Horst IC; Hillege HL; Voors AA
Am Heart J; 2012 Nov; 164(5):742-749.e3. PubMed ID: 23137505
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-products as long-term predictors of death and reinfarction after an acute coronary syndrome.
Raposeiras-Roubín S; Rodino-Janeiro BK; Paradela-Dobarro B; Almansour H; Grigorian-Shamagian L; Reino-Maceiras MV; García-Acuña JM; González-Juanatey JR; Álvarez E
Biomark Med; 2015; 9(3):209-16. PubMed ID: 25731208
[TBL] [Abstract][Full Text] [Related]
15. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.
Colhoun HM; Betteridge DJ; Durrington P; Hitman G; Neil A; Livingstone S; Charlton-Menys V; Bao W; Demicco DA; Preston GM; Deshmukh H; Tan K; Fuller JH
Diabetes; 2011 Sep; 60(9):2379-85. PubMed ID: 21771973
[TBL] [Abstract][Full Text] [Related]
16. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
Aslan EI; Ozkara G; Kilicarslan O; Ser OS; Bostan C; Yildiz A; Diren Borekcioglu A; Ozturk O; Kucukhuseyin O; Yilmaz Aydogan H
Gene; 2024 Jul; 916():148450. PubMed ID: 38588932
[TBL] [Abstract][Full Text] [Related]
17. Association of four differently processed diets with plasma and urine advanced glycation end products and serum soluble receptor for advanced glycation end products concentration in healthy dogs.
Bridglalsingh S; Archer-Hartmann S; Azadi P; Barbier de La Serre C; Remillard RL; Sunvold GD; Bartges JW
J Anim Physiol Anim Nutr (Berl); 2024 May; 108(3):735-751. PubMed ID: 38279966
[TBL] [Abstract][Full Text] [Related]
18. Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study.
Heier M; Margeirsdottir HD; Gaarder M; Stensæth KH; Brunborg C; Torjesen PA; Seljeflot I; Hanssen KF; Dahl-Jørgensen K
Cardiovasc Diabetol; 2015 Sep; 14():126. PubMed ID: 26408307
[TBL] [Abstract][Full Text] [Related]
19. Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I.
Basta G; Del Turco S; Marchi F; Navarra T; Battaglia D; Mercuri A; Mazzone A; Berti S
Coron Artery Dis; 2011 Dec; 22(8):590-4. PubMed ID: 22072229
[TBL] [Abstract][Full Text] [Related]
20. Activation of the receptor for advanced glycation end products system in women with severe preeclampsia.
Oliver EA; Buhimschi CS; Dulay AT; Baumbusch MA; Abdel-Razeq SS; Lee SY; Zhao G; Jing S; Pettker CM; Buhimschi IA
J Clin Endocrinol Metab; 2011 Mar; 96(3):689-98. PubMed ID: 21325454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
